SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Aptevo Reports 21% of Frontline AML Patients Reach Stem Cell Transplant

Aptevo said 21% of frontline acute myeloid leukemia patients reached stem cell transplant after mipletamig combination therapy.

APVO

Related stories